Badge
11,371 badges added since 01 January 2025
ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Zydus Group A.I CyberSecurity Scoring

Zydus Group

Company Details

Linkedin ID:

zydusuniverse

Employees number:

20,196

Number of followers:

772,867

NAICS:

3254

Industry Type:

Pharmaceutical Manufacturing

Homepage:

zyduslife.com

IP Addresses:

0

Company ID:

ZYD_5657469

Scan Status:

In-progress

AI scoreZydus Group Risk Score (AI oriented)

Between 750 and 799

https://images.rankiteo.com/companyimages/zydusuniverse.jpeg
Zydus Group Pharmaceutical Manufacturing
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreZydus Group Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/zydusuniverse.jpeg
Zydus Group Pharmaceutical Manufacturing
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

Zydus Group Company CyberSecurity News & History

Past Incidents
0
Attack Types
0
No data available
Ailogo

Zydus Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for Zydus Group

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Zydus Group in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Zydus Group in 2026.

Incident Types Zydus Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Zydus Group in 2026.

Incident History — Zydus Group (X = Date, Y = Severity)

Zydus Group cyber incidents detection timeline including parent company and subsidiaries

Zydus Group Company Subsidiaries

SubsidiaryImage

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Loading...
similarCompanies

Zydus Group Similar Companies

Fundada há mais de 60 anos e com capital 100% nacional, a EMS é a líder do mercado farmacêutico brasileiro há 19 anos consecutivos, pertencente ao Grupo NC, um dos maiores conglomerados brasileiros. A empresa ocupa também a liderança no segmento de genéricos desde 2013 (IQVIA 2019) e está entre os

Merck

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccine

MANKIND PHARMA LTD

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,

Catalent

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier li

Servier

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its

Eli Lilly and Company

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and

Alembic Pharmaceuticals Limited

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol

Fresenius Kabi

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf

Hikma Pharmaceuticals

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists

newsone

Zydus Group CyberSecurity News

January 27, 2025 08:00 AM
Pankaj Patel Awarded Padma Bhushan for Contributions to Lifesciences

Pankaj Patel, the esteemed Chairman of Zydus Group, has been conferred with the prestigious Padma Bhushan, one of India's highest civilian honors.

December 05, 2024 08:00 AM
Zydus Wellness expands healthy snacks portfolio with Naturell India acquisition

Indian consumer company Zydus Wellness has acquired healthy snacking company Naturell India for a total value of Rs3.9bn ($46m).

November 28, 2024 08:00 AM
Hello, this is your chatbot leaking: WotNot exposes 346K sensitive customer files

Passports, detailed medical records, resumes, and other sensitive personal records were exposed in a database belonging to WotNot, an Indian AI startup.

February 17, 2023 08:00 AM
Medtronic, Zydus Hospitals to facilitate remote stroke care using AI

Zydus Hospitals in Ahmedabad and Medtronic India have tied up to launch an AI-enabled hub-and-spoke network to support stroke patients in the western coastal...

August 23, 2021 07:00 AM
India regulator grants EUA to Zydus Cadila’s DNA vaccine for Covid-19

The Drugs Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to Zydus Cadila's plasmid deoxyribonucleic acid (DNA) vaccine, ZyCoV...

August 20, 2021 07:00 AM
India gives emergency approval for world's first COVID-19 DNA vaccine

India's drug regulator has granted emergency use approval for Zydus Cadila's COVID-19 vaccine, the world's first DNA shot against the...

July 02, 2021 07:00 AM
Zydus reports positive Phase III data of first DNA Covid-19 vaccine

Zydus Cadila has reported positive interim results from the Phase III clinical trial of its plasmid DNA Covid-19 vaccine candidate, ZyCoV-D.

March 10, 2020 07:00 AM
India wins the dash for NASH, as Zydus Cadila’s saroglitazar wins first approval

HONG KONG – Cadila Healthcare Ltd. (Zydus Cadila) has won approval for its saroglitazar to be used as the treatment of non-cirrhotic...

October 26, 2016 07:00 AM
Kumar Manglam Birla appointed new IIM-A Chairman

Noted industrialist and Chairman of Aditya Birla Group Kumar Mangalam Birla has been appointed as the new Chairman of Indian Institute of Management Ahmedabad...

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

Zydus Group CyberSecurity History Information

Official Website of Zydus Group

The official website of Zydus Group is http://www.zyduslife.com.

Zydus Group’s AI-Generated Cybersecurity Score

According to Rankiteo, Zydus Group’s AI-generated cybersecurity score is 781, reflecting their Fair security posture.

How many security badges does Zydus Group’ have ?

According to Rankiteo, Zydus Group currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Zydus Group been affected by any supply chain cyber incidents ?

According to Rankiteo, Zydus Group has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Zydus Group have SOC 2 Type 1 certification ?

According to Rankiteo, Zydus Group is not certified under SOC 2 Type 1.

Does Zydus Group have SOC 2 Type 2 certification ?

According to Rankiteo, Zydus Group does not hold a SOC 2 Type 2 certification.

Does Zydus Group comply with GDPR ?

According to Rankiteo, Zydus Group is not listed as GDPR compliant.

Does Zydus Group have PCI DSS certification ?

According to Rankiteo, Zydus Group does not currently maintain PCI DSS compliance.

Does Zydus Group comply with HIPAA ?

According to Rankiteo, Zydus Group is not compliant with HIPAA regulations.

Does Zydus Group have ISO 27001 certification ?

According to Rankiteo,Zydus Group is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of Zydus Group

Zydus Group operates primarily in the Pharmaceutical Manufacturing industry.

Number of Employees at Zydus Group

Zydus Group employs approximately 20,196 people worldwide.

Subsidiaries Owned by Zydus Group

Zydus Group presently has no subsidiaries across any sectors.

Zydus Group’s LinkedIn Followers

Zydus Group’s official LinkedIn profile has approximately 772,867 followers.

NAICS Classification of Zydus Group

Zydus Group is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Zydus Group’s Presence on Crunchbase

No, Zydus Group does not have a profile on Crunchbase.

Zydus Group’s Presence on LinkedIn

Yes, Zydus Group maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/zydusuniverse.

Cybersecurity Incidents Involving Zydus Group

As of January 22, 2026, Rankiteo reports that Zydus Group has not experienced any cybersecurity incidents.

Number of Peer and Competitor Companies

Zydus Group has an estimated 5,507 peer or competitor companies worldwide.

Zydus Group CyberSecurity History Information

How many cyber incidents has Zydus Group faced ?

Total Incidents: According to Rankiteo, Zydus Group has faced 0 incidents in the past.

What types of cybersecurity incidents have occurred at Zydus Group ?

Incident Types: The types of cybersecurity incidents that have occurred include .

Incident Details

What are the most common types of attacks the company has faced ?

Additional Questions

cve

Latest Global CVEs (Not Company-Specific)

Description

Backstage is an open framework for building developer portals, and @backstage/backend-defaults provides the default implementations and setup for a standard Backstage backend app. Prior to versions 0.12.2, 0.13.2, 0.14.1, and 0.15.0, the `FetchUrlReader` component, used by the catalog and other plugins to fetch content from URLs, followed HTTP redirects automatically. This allowed an attacker who controls a host listed in `backend.reading.allow` to redirect requests to internal or sensitive URLs that are not on the allowlist, bypassing the URL allowlist security control. This is a Server-Side Request Forgery (SSRF) vulnerability that could allow access to internal resources, but it does not allow attackers to include additional request headers. This vulnerability is fixed in `@backstage/backend-defaults` version 0.12.2, 0.13.2, 0.14.1, and 0.15.0. Users should upgrade to this version or later. Some workarounds are available. Restrict `backend.reading.allow` to only trusted hosts that you control and that do not issue redirects, ensure allowed hosts do not have open redirect vulnerabilities, and/or use network-level controls to block access from Backstage to sensitive internal endpoints.

Risk Information
cvss3
Base: 3.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:N/A:N
Description

Backstage is an open framework for building developer portals, and @backstage/cli-common provides config loading functionality used by the backend and command line interface of Backstage. Prior to version 0.1.17, the `resolveSafeChildPath` utility function in `@backstage/backend-plugin-api`, which is used to prevent path traversal attacks, failed to properly validate symlink chains and dangling symlinks. An attacker could bypass the path validation via symlink chains (creating `link1 → link2 → /outside` where intermediate symlinks eventually resolve outside the allowed directory) and dangling symlinks (creating symlinks pointing to non-existent paths outside the base directory, which would later be created during file operations). This function is used by Scaffolder actions and other backend components to ensure file operations stay within designated directories. This vulnerability is fixed in `@backstage/backend-plugin-api` version 0.1.17. Users should upgrade to this version or later. Some workarounds are available. Run Backstage in a containerized environment with limited filesystem access and/or restrict template creation to trusted users.

Risk Information
cvss3
Base: 6.3
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:N
Description

Backstage is an open framework for building developer portals. Multiple Scaffolder actions and archive extraction utilities were vulnerable to symlink-based path traversal attacks. An attacker with access to create and execute Scaffolder templates could exploit symlinks to read arbitrary files via the `debug:log` action by creating a symlink pointing to sensitive files (e.g., `/etc/passwd`, configuration files, secrets); delete arbitrary files via the `fs:delete` action by creating symlinks pointing outside the workspace, and write files outside the workspace via archive extraction (tar/zip) containing malicious symlinks. This affects any Backstage deployment where users can create or execute Scaffolder templates. This vulnerability is fixed in `@backstage/backend-defaults` versions 0.12.2, 0.13.2, 0.14.1, and 0.15.0; `@backstage/plugin-scaffolder-backend` versions 2.2.2, 3.0.2, and 3.1.1; and `@backstage/plugin-scaffolder-node` versions 0.11.2 and 0.12.3. Users should upgrade to these versions or later. Some workarounds are available. Follow the recommendation in the Backstage Threat Model to limit access to creating and updating templates, restrict who can create and execute Scaffolder templates using the permissions framework, audit existing templates for symlink usage, and/or run Backstage in a containerized environment with limited filesystem access.

Risk Information
cvss3
Base: 7.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:L
Description

FastAPI Api Key provides a backend-agnostic library that provides an API key system. Version 1.1.0 has a timing side-channel vulnerability in verify_key(). The method applied a random delay only on verification failures, allowing an attacker to statistically distinguish valid from invalid API keys by measuring response latencies. With enough repeated requests, an adversary could infer whether a key_id corresponds to a valid key, potentially accelerating brute-force or enumeration attacks. All users relying on verify_key() for API key authentication prior to the fix are affected. Users should upgrade to version 1.1.0 to receive a patch. The patch applies a uniform random delay (min_delay to max_delay) to all responses regardless of outcome, eliminating the timing correlation. Some workarounds are available. Add an application-level fixed delay or random jitter to all authentication responses (success and failure) before the fix is applied and/or use rate limiting to reduce the feasibility of statistical timing attacks.

Risk Information
cvss3
Base: 3.7
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
Description

The Flux Operator is a Kubernetes CRD controller that manages the lifecycle of CNCF Flux CD and the ControlPlane enterprise distribution. Starting in version 0.36.0 and prior to version 0.40.0, a privilege escalation vulnerability exists in the Flux Operator Web UI authentication code that allows an attacker to bypass Kubernetes RBAC impersonation and execute API requests with the operator's service account privileges. In order to be vulnerable, cluster admins must configure the Flux Operator with an OIDC provider that issues tokens lacking the expected claims (e.g., `email`, `groups`), or configure custom CEL expressions that can evaluate to empty values. After OIDC token claims are processed through CEL expressions, there is no validation that the resulting `username` and `groups` values are non-empty. When both values are empty, the Kubernetes client-go library does not add impersonation headers to API requests, causing them to be executed with the flux-operator service account's credentials instead of the authenticated user's limited permissions. This can result in privilege escalation, data exposure, and/or information disclosure. Version 0.40.0 patches the issue.

Risk Information
cvss3
Base: 5.3
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=zydusuniverse' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge